Diabetes & Metabolism Journal

Original Article

Metabolic Risk/Epidemiology
Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study: Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park; Diabetes Metab J. 2023;47(2):220-231. Published online January 12, 2023; DOI: https://doi.org/10.4093/dmj.2021.0327

65,535 View
282 Download
9 Web of Science
10 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
We investigated whether metabolic dysfunction-associated fatty liver disease (MAFLD) is associated with an elevated risk of all-cause and cardiovascular mortality using a large-scale health examination cohort.
Methods
A total of 394,835 subjects in the Kangbuk Samsung Health Study cohort were enrolled from 2002 to 2012. Participants were categorized by the presence of nonalcoholic fatty liver disease (NAFLD) and MAFLD as follows: normal subjects; patients with both NAFLD and MAFLD; patients with NAFLD only; and patients with MAFLD only. Cox proportional hazards models were used to analyze the risk of mortality.
Results
During a median 5.7 years of follow-up, 20.69% was patients with both NAFLD and MAFLD, 1.51% was patients with NAFLD only, and 4.29% was patients with MAFLD only. All-cause and cardiovascular death was higher in patients with MAFLD than those without MAFLD (P<0.001, respectively). In patients with MAFLD only, the hazard ratio (HR) of all-cause and cardiovascular death was 1.35 (95% confidence interval [CI], 1.13 to 1.60) and 1.90 (95% CI, 1.26 to 2.88) after adjusting for age, which lost its statistical significance by multivariable adjustments. Compared to patients with less than two components of metabolic dysfunction, patients with more than two components of metabolic dysfunction were a higher risk of cardiovascular death (HR, 2.05; 95% CI, 1.25 to 3.38) and only women with more than two components of metabolic dysfunction were a higher risk of all-cause death (HR, 1.44; 95% CI, 1.02 to 2.03).
Conclusion
MAFLD criteria could identify a high-risk group for all-cause and cardiovascular death.

Citations

Citations to this article as recorded by

Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
Eugene Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Sang Hoon Ahn, Yong-ho Lee, Seung Up Kim
Metabolism.2024; 152: 155789. CrossRef
Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study
Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
BMJ.2024; : e076388. CrossRef
Sex differences in mortality and liver‐related events in non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Huimin Zhou, Haiyan Chen, Hanxiao Lu, Bo Wu, Shuo Zhang, Yuanlong Gu, Guangwen Zhou, Jie Xiang, Jun Yang
Liver International.2024;[Epub] CrossRef
Association between dietary carbohydrate to fiber ratio and metabolic dysfunction associated fatty liver disease in adults: evidence from the NHANES 2017–2020
Zhenmin Liu, Taiyong Fang
Journal of Health, Population and Nutrition.2024;[Epub] CrossRef
Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis
Ghazala S Virk, Jaahnavi Vajje, Nausheen K Virk, Raam Mannam, Wajeeh Rehman, Naglaa G Ghobriel , Irfan-ud-din Mian, Muhammad Usama
Cureus.2023;[Epub] CrossRef
Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: Results from the NHANES study
Zhi-Qin Xie, Hong-Xia Li, Bing-Kun Wang, Zhao-Ming Yang, Zi-Yu Zhang, Wen-Liang Tan, Wen-Xin Li, Qing-Bin Wang, Lei Yang, Hong-Kai Zhuang, Chen-Wei Tang, Chang-Zhen Shang, Ya-Jin Chen
European Journal of Internal Medicine.2023; 110: 62. CrossRef
Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
Han Na Jung, Chang Hee Jung
Diabetes & Metabolism Journal.2023; 47(2): 198. CrossRef
Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis
Hye Jin Chun, Eun Ran Kim, Minyoung Lee, Da Hyun Choi, Soo Hyun Kim, Eugene Shin, Jin-Hong Kim, Jin Won Cho, Dai Hoon Han, Bong-Soo Cha, Yong-ho Lee
Metabolism.2023; 145: 155612. CrossRef
Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes
Karl Vaz, Daniel Clayton-Chubb, Ammar Majeed, John Lubel, David Simmons, William Kemp, Stuart K. Roberts
Hepatology International.2023; 17(5): 1082. CrossRef
Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Soyeon Shin, Jaeyoung Kim, Ju Yeon Lee, Jun Kim, Chang-Myung Oh
Journal of Obesity & Metabolic Syndrome.2023; 32(4): 289. CrossRef

Brief Report

Metabolic Risk/Epidemiology
Trends in the Prevalence of Obesity and Its Phenotypes Based on the Korea National Health and Nutrition Examination Survey from 2007 to 2017 in Korea: Sang Ouk Chin, You-Cheol Hwang, Hong-Yup Ahn, Ji Eun Jun, In-Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung; Diabetes Metab J. 2022;46(5):808-812. Published online March 8, 2022; DOI: https://doi.org/10.4093/dmj.2021.0226

3,898 View
215 Download
2 Web of Science
2 Crossref

Abstract PDF Supplementary Material PubReader ePub

This study used data from the Korea National Health and Nutrition Examination Survey IV–VII from 2007 to identify the prevalence of obesity and its phenotypes (metabolically unhealthy obesity [MUO] and metabolically healthy obesity [MHO]) and their secular changes. The prevalence of obesity in Korea increased with significant secular changes observed (β=0.326, P trend <0.01) between 2007 and 2017, and especially in men (β=0.682, P trend <0.001) but not in women. The changes in the prevalence of obesity during the study period were different between men and women (P=0.001). The prevalence of MUO significantly increased only in men (β=0.565, P trend <0.01), while that of MHO increased only in women (β=0.179, P<0.05), especially in the younger age group (β=0.308, P<0.01).

Citations

Citations to this article as recorded by

Hormonal Gut–Brain Signaling for the Treatment of Obesity
Eun Roh, Kyung Mook Choi
International Journal of Molecular Sciences.2023; 24(4): 3384. CrossRef
Differences of Regional Fat Distribution Measured by Magnetic Resonance Imaging According to Obese Phenotype in Koreans
Ha-Neul Choi, Hyunjung Lim, Young-Seol Kim, Sang-Youl Rhee, Jung-Eun Yim
Metabolic Syndrome and Related Disorders.2022; 20(10): 551. CrossRef

Original Article

Others
Comparison of the Usefulness of the Updated Homeostasis Model Assessment (HOMA2) with the Original HOMA1 in the Prediction of Type 2 Diabetes Mellitus in Koreans: Young Seok Song, You-Cheol Hwang, Hong-Yup Ahn, Cheol-Young Park; Diabetes Metab J. 2016;40(4):318-325. Published online May 27, 2016; DOI: https://doi.org/10.4093/dmj.2016.40.4.318

4,360 View
81 Download
39 Web of Science
42 Crossref

Abstract PDF PubReader

Background

The original homeostasis model assessment (HOMA1) and the updated HOMA model (HOMA2) have been used to evaluate insulin resistance (IR) and β-cell function, but little is known about the usefulness of HOMA2 for the prediction of diabetes in Koreans. The aim of this study was to demonstrate the usefulness of HOMA2 as a predictor of type 2 diabetes mellitus in Koreans without diabetes.

Methods

The study population consisted of 104,694 Koreans enrolled at a health checkup program and followed up from 2001 to 2012. Participants were divided into a normal glucose tolerance (NGT) group and a pre-diabetes group according to fasting glucose and glycosylated hemoglobin levels. Anthropometric and laboratory data were measured at the baseline checkup, and HOMA values were calculated at the baseline and follow-up checkups. The hazard ratios (HRs) of the HOMA1 and HOMA2 values and the prevalence of diabetes at follow-up were evaluated using a multivariable Cox proportional hazards model and Kaplan-Meier analysis.

Results

After adjusting for several diabetes risk factors, all of the HOMA values except 1/HOMA1-β and 1/HOMA2-β in the NGT group were significant predictors of the progression to diabetes. In the NGT group, there was no significant difference in HOMA1-IR (HR, 1.09; 95% confidence interval [CI], 1.04 to 1.14) and HOMA2-IR (HR, 1.11; 95% CI, 1.04 to 1.19). However, in the pre-diabetes group, 1/HOMA2-β was a more powerful marker (HR, 1.29; 95% CI, 1.26 to 1.31) than HOMA1-IR (HR, 1.23; 95% CI, 1.19 to 1.28) or 1/HOMA1-β (HR, 1.14; 95% CI, 1.12 to 1.16). In the non-diabetic group (NGT+pre-diabetes), 1/HOMA2-β was also a stronger predictor of diabetes (HR, 1.27; 95% CI, 1.25 to 1.29) than HOMA1-IR (HR, 1.14; 95% CI, 1.12 to 1.15) or 1/HOMA1-β (HR, 1.13; 95% CI, 1.11 to 1.14).

Conclusion

HOMA2 is more predictive than HOMA1 for the progression to diabetes in pre-diabetes or non-diabetic Koreans.

Citations

Citations to this article as recorded by

Non-linear associations of HOMA2-IR with all-cause mortality in general populations: insights from NHANES 1999–2006
Aikai Zhang, Lingchen Huang, Min Tang
BMC Public Health.2024;[Epub] CrossRef
An acute exercise at low to moderate intensity attenuated postprandial lipemia and insulin responses
Lisa L. Ji, Vicki S. Fretwell, Abel Escamilla, Wanxiang Yao, Tianou Zhang, Meizi He, John Q. Zhang
Journal of Exercise Science & Fitness.2024; 22(1): 14. CrossRef
Insufficient compensatory pancreatic β-cells function might be closely associated with hyperuricemia in U.S. adults: evidence from the National Health and Nutrition Examination Survey
Tianran Shen, Qiutong Zheng, Liling Zhong, Xia Zeng, Xiaojing Yuan, Fengxin Mo, Shiheng Zhu, Wenhan Yang, Qingsong Chen
BMC Public Health.2024;[Epub] CrossRef
Glycated haemoglobin, HOMA2‐B, C‐peptide to glucose ratio and type 2 diabetes clusters as predictors for therapy failure in individuals with type 2 diabetes without insulin therapy: A registry analysis
Faisal Aziz, Christoph Sternad, Caren Sourij, Lisa Knoll, Harald Kojzar, Anna Schranz, Alexandra Bürger, Harald Sourij, Felix Aberer
Diabetes, Obesity and Metabolism.2024; 26(3): 1082. CrossRef
Nghiên cứu tương quan giữa chỉ số đề kháng insulin và chỉ số khối cơ thể ở bệnh nhân tiền đái tháo đường có tăng huyết áp
Linh Dương
Journal of Clinical Medicine- Hue Central Hospital.2024;[Epub] CrossRef
Bridelia ferruginea inhibits key carbohydrate digesting enzyme and intestinal glucose absorption and modulates glucose metabolism in diabetic rats
Olajumoke Oyebode, Lindiwe Zuma, Ochuko Lucky Erukainure, Neil Koorbanally, Md. Shahidul Islam
Archives of Physiology and Biochemistry.2023; 129(3): 671. CrossRef
Impact of Pancreatic β-Cell Function on Clopidogrel Responsiveness and Outcomes in Chinese Nondiabetic Patients Undergoing Elective Percutaneous Coronary Intervention
Xiliang Zhao, Jin Wang, Quan Li, Yicong Ye, Yong Zeng
Cardiovascular Drugs and Therapy.2023; 37(3): 487. CrossRef
Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study
Shang-Feng Tsai, Chao-Tung Yang, Wei-Ju Liu, Chia-Lin Lee
eClinicalMedicine.2023; 58: 101934. CrossRef
Association of the triglyceride‐glucose index with subclinical left ventricular dysfunction in type 2 diabetes mellitus patients: A retrospective cross‐sectional study
Qi‐chao Sun, Jie Liu, Ran Meng, Ning Zhang, Jing Yao, Fan Yang, Da‐long Zhu
Journal of Diabetes Investigation.2023; 14(8): 953. CrossRef
Fasting indices of glucose-insulin-metabolism across life span and prediction of glycemic deterioration in children with obesity from new diagnostic cut-offs
Maximiliane Chiara Hammel, Robert Stein, Jürgen Kratzsch, Mandy Vogel, Alexander J. Eckert, Rima Destya Triatin, Marco Colombo, Christof Meigen, Ronny Baber, Juraj Stanik, Ulrike Spielau, Anette Stoltze, Kerstin Wirkner, Anke Tönjes, Harold Snieder, Reinh
The Lancet Regional Health - Europe.2023; 30: 100652. CrossRef
The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis
Adisa Poljo, Stephan Kopf, Alba Sulaj, Stephanie Roessler, Thomas Albrecht, Benjamin Goeppert, Sarah Bojko, Beat P. Müller-Stich, Adrian T. Billeter
Surgery for Obesity and Related Diseases.2023; 19(12): 1421. CrossRef
Glutamine Defended the Kidneys Versus Lead Intoxication Via Elevating Endogenous Antioxidants, Reducing Inflammation and Carbonyl Stress, as well as Improving Insulin Resistance and Dyslipidemia
Sina Mahdavifard, Najafzadeh Nowruz
Biological Trace Element Research.2023;[Epub] CrossRef
Sex and genetic background define the metabolic, physiologic, and molecular response to protein restriction
Cara L. Green, Heidi H. Pak, Nicole E. Richardson, Victoria Flores, Deyang Yu, Jay L. Tomasiewicz, Sabrina N. Dumas, Katherine Kredell, Jesse W. Fan, Charlie Kirsh, Krittisak Chaiyakul, Michaela E. Murphy, Reji Babygirija, Gregory A. Barrett-Wilt, Joshua
Cell Metabolism.2022; 34(2): 209. CrossRef
Associations of the HOMA2‐%B and HOMA2‐IR with progression to diabetes and glycaemic deterioration in young and middle‐aged Chinese
Baoqi Fan, Hongjiang Wu, Mai Shi, Aimin Yang, Eric S. H. Lau, Claudia H. T. Tam, Dandan Mao, Cadmon K. P. Lim, Alice P. S. Kong, Ronald C. W. Ma, Elaine Chow, Andrea O. Y. Luk, Juliana C. N. Chan
Diabetes/Metabolism Research and Reviews.2022;[Epub] CrossRef
Triglyceride and glucose index is a simple and easy‐to‐calculate marker associated with nonalcoholic fatty liver disease
Kyung‐Soo Kim, Sangmo Hong, Hong‐Yup Ahn, Cheol‐Young Park
Obesity.2022; 30(6): 1279. CrossRef
Protective effect of acetylcysteine, histidine, and their combination against diabetes vascular complications in type-2 diabetic rats via reducing NF-kβ pathway signaling
Sina Mahdavifard, Manochehr Nakhjavani
Journal of Diabetes & Metabolic Disorders.2022; 21(2): 1233. CrossRef
Visceral fat might impact left ventricular remodeling through changes in arterial stiffness in type 2 diabetes: A cross-sectional study
Haishan Huang, Jing Jin, Yanshan Chen, Lina Wang, Jingyi Zhong, Zhenguo Chen, Lingling Xu
International Journal of Cardiology.2022; 368: 78. CrossRef
The effect of berberine and fenugreek seed co-supplementation on inflammatory factor, lipid and glycemic profile in patients with type 2 diabetes mellitus: a double-blind controlled randomized clinical trial
Shima Nematollahi, Gholam Reza Pishdad, Mehrnoosh Zakerkish, Foroogh Namjoyan, Kambiz Ahmadi Angali, Fatemeh Borazjani
Diabetology & Metabolic Syndrome.2022;[Epub] CrossRef
Association between changes in pancreatic morphology and vascular complications in subjects with type 2 diabetes mellitus: a retrospective study
Yuichiro Iwamoto, Tomohiko Kimura, Fuminori Tatsumi, Toshitomo Sugisaki, Masato Kubo, Erina Nakao, Kazunori Dan, Ryo Wamata, Hideyuki Iwamoto, Kaio Takahashi, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mun
Scientific Reports.2022;[Epub] CrossRef
Clustering patterns of metabolic syndrome: A cross-sectional study in children and adolescents in Kyiv
Maiia H. Aliusef, Ganna V. Gnyloskurenko, Alina V. Churylina, Inga O. Mityuryayeva
Frontiers in Pediatrics.2022;[Epub] CrossRef
Circulating spexin levels are influenced by the glycemic status and correlated with pancreatic β-cell function in Chinese subjects
Jiarong Dai, Yunzhi Ni, Di Wu, Yaojing Jiang, Shuoshuo Jin, Shan Zhang, Xuemei Yu, Rui Liu
Acta Diabetologica.2022; 60(2): 305. CrossRef
Association between the triglyceride–glucose index and diabetic nephropathy in patients with type 2 diabetes: A cross‐sectional study
Li Liu, Rui Xia, Xiaoqing Song, Benping Zhang, Wentao He, Xinrong Zhou, Shengzhong Li, Gang Yuan
Journal of Diabetes Investigation.2021; 12(4): 557. CrossRef
The insulin resistance by triglyceride glucose index and risk for dementia: population-based study
Sangmo Hong, Kyungdo Han, Cheol-Young Park
Alzheimer's Research & Therapy.2021;[Epub] CrossRef
Determinants of type 2 diabetes remission after bariatric surgery in obese Japanese patients: a retrospective cohort study
Masahiro Ohira, Yasuhiro Watanabe, Takashi Yamaguchi, Atsuhito Saiki, Shoko Nakamura, Shou Tanaka, Naomi Shimizu, Taiki Nabekura, Takashi Oshiro, Ichiro Tatsuno
Diabetology International.2021; 12(4): 379. CrossRef
Sakarya Eğitim ve Araştırma Hastanesine Başvuran Hastaların HOMA-IR Değerlerinin Yaş ve Cinsiyet Faktörü Açısından Değerlendirilmesi
Mehmet ÖZDİN, Hayrullah YAZAR, Durhasan MUNDAN
Mustafa Kemal Üniversitesi Tıp Dergisi.2021; 12(42): 1. CrossRef
Feeding pattern, biochemical, anthropometric and histological effects of prolonged ad libitum access to sucrose, honey and glucose-fructose solutions in Wistar rats
Carmen Alejandrina Virgen-Carrillo, Alma Gabriela Martínez Moreno, Juan José Rodríguez-Gudiño, Jessica Elizabeth Pineda-Lozano
Nutrition Research and Practice.2021; 15(2): 187. CrossRef
The effect of curcumin and zinc co‐supplementation on glycemic parameters in overweight or obese prediabetic subjects: A phase 2 randomized, placebo‐controlled trial with a multi‐arm, parallel‐group design
Majid Karandish, Hassan Mozaffari‐khosravi, Seyed Mohammad Mohammadi, Bahman Cheraghian, Maryam Azhdari
Phytotherapy Research.2021; 35(8): 4377. CrossRef
The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study
Won Jun Kim, Jung Hyun Noh, Kyungdo Han, Cheol-Young Park
Journal of Alzheimer's Disease.2021; 81(3): 1263. CrossRef
Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial
Eun-Young Lee, Jae-Seung Yun, Seon-Ah Cha, Sun-Young Lim, Jin-Hee Lee, Yu-Bae Ahn, Kun-Ho Yoon, Seung-Hyun Ko
International Journal of Environmental Research and Public Health.2021; 18(10): 5300. CrossRef
Enhancement of Serum Myonectin Levels by Progressive Resistance Training in Rats Fed with High-Fat Diet and Sucrose Solution
Alireza Safarzade, Hadi Safarpour
Zahedan Journal of Research in Medical Sciences.2021;[Epub] CrossRef
Pancreatic β-Cell Dysfunction Is Associated with Nonalcoholic Fatty Liver Disease
Xu Chen, Jinghe Xiao, Juan Pang, Shen Chen, Qing Wang, Wenhua Ling
Nutrients.2021; 13(9): 3139. CrossRef
The correlation between serum resistin and toll-like receptor-4 with insulin resistance in hypertensive subjects with or without type 2 diabetes mellitus
Mustafa Al-Taie, Rayah Baban, Mouayed Hamed
Baghdad Journal of Biochemistry and Applied Biological Sciences.2021; 2(04): 203. CrossRef
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, Javier Crespo, José Luis Calleja, Carmelo García-Monzón, Judith Gómez-Camarero, Joan Caballería, Oreste Lo Iacono, Luis Ibañez, Javier García-Samaniego, Agustín Albillos, Rubén Francés, Conrado Fernández-R
Journal of Hepatology.2020; 73(1): 17. CrossRef
Are the Different Diabetes Subgroups Correlated With All-Cause, Cancer-Related, and Cardiovascular-Related Mortality?
Peng-Fei Li, Wei-Liang Chen
The Journal of Clinical Endocrinology & Metabolism.2020; 105(12): e4240. CrossRef
Avoiding holiday seasonal weight gain with nutrient-supported intermittent energy restriction: a pilot study
Steven P. Hirsh, Marianne Pons, Steven V. Joyal, Andrew G. Swick
Journal of Nutritional Science.2019;[Epub] CrossRef
Peripartum Management of Gestational Diabetes Using a Digital Health Care Service: A Pilot, Randomized Controlled Study
Ji-Hee Sung, Da Young Lee, Kyoung Pil Min, Cheol-Young Park
Clinical Therapeutics.2019; 41(11): 2426. CrossRef
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Bernd Richter, Bianca Hemmingsen, Maria-Inti Metzendorf, Yemisi Takwoingi
Cochrane Database of Systematic Reviews.2018;[Epub] CrossRef
The cut-off values of surrogate measures for insulin resistance in the Korean population according to the Korean Genome and Epidemiology Study (KOGES)
Bongyoung Kim, Hyun Young Choi, Wonhee Kim, Chiwon Ahn, Juncheol Lee, Jae Guk Kim, Jihoon Kim, Hyungoo Shin, Jae Myung Yu, Shinje Moon, Taulant Muka
PLOS ONE.2018; 13(11): e0206994. CrossRef
Testing for HbA1c, in addition to the oral glucose tolerance test, in screening for abnormal glucose regulation helps to reveal patients with early β-cell function impairment
Yu-Hsuan Li, Wayne Huey-Herng Sheu, Wen-Jane Lee, I-Te Lee, Shih-Yi Lin, Wen-Lieng Lee, Kae-Woei Liang, Jun-Sing Wang
Clinical Chemistry and Laboratory Medicine (CCLM).2018; 56(8): 1345. CrossRef
Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance
Sikandar Hayat Khan, Farah Sobia, Najmusaqib Khan Niazi, Syed Mohsin Manzoor, Nadeem Fazal, Fowad Ahmad
Diabetology & Metabolic Syndrome.2018;[Epub] CrossRef
Pancreatic β-Cell Function and Prognosis of Nondiabetic Patients With Ischemic Stroke
Yuesong Pan, Weiqi Chen, Jing Jing, Huaguang Zheng, Qian Jia, Hao Li, Xingquan Zhao, Liping Liu, Yongjun Wang, Yan He, Yilong Wang
Stroke.2017; 48(11): 2999. CrossRef
Association of serum pancreatic derived factor ( PANDER) with beta-cell dysfunction in type 2 diabetes mellitus
Miral M. Shehata, Mohamed M. Kamal, Mohamed H. El-Hefnawy, Hala O. EL-Mesallamy
Journal of Diabetes and its Complications.2017; 31(4): 748. CrossRef

First
Prev
Page of 1
Next
Last

Search